Skip to content
ELIGARD® Information Center
  • Prescriber
  • Injector
  • Administrator
  • Home Page
  • All Topics
  • Contact
Menu

Quick links

  • Mixing
  • Administration
  • Medical Information Request Form

Suggested searches

All Topics

Whatever your role, all of the information you need to prescribe, inject and manage ELIGARD can be found right here.

ELIGARD Overview

  • Dosing Calculator
  • Description
  • Current Science
  • Class & Indication
  • Innovative Delivery System
  • USA Assembled
  • Dosage Options
  • Medical Information Request Form

Clinical Data

  • Clinical Studies
  • Efficacy
  • Clinical Pharmacology
  • Non-Clinical Toxicology
  • References

ELIGARD Mixing & Administration

  • Contents of Packaging
  • Preparation
  • Mixing
  • Tips & Troubleshooting
  • Administration

ELIGARD Pre-Connected Syringe System Mixing & Administration

  • Contents of Packaging
  • Preparation
  • Mixing
  • Administration
  • Tips & Troubleshooting

Safety

  • Contraindications
  • Warnings & Precautions
  • Adverse Reactions
  • Drug Interactions
  • Specific Populations
  • Overdosage

Storage

  • Cold Storage & Shipping
  • Room Temperature Storage

Ordering

  • How Supplied
  • NDC Numbers & Codes
  • Inventory Management

Patient Resources

  • Patient Care Guide
  • About Prostate Cancer
  • Patient Counseling

Finances & Access

  • Finances & Contracting
  • Patient Access
Tolmar Pharmaceuticals, Inc.

©2023 Tolmar, Inc. All rights reserved. Tolmar, ELIGARD, ATRIGEL, TOLMARsync and Tolmar Total Solutions are trademarks of the Tolmar group.

Third party trademarks, product names, and copyrights belong to their respective owners.

This site is intended for use by U.S. residents only.

  • Column 1
    • ELIGARD Overview
    • Clinical Data
    • Storage
    • Safety
  • Column 2
    • ELIGARD Mixing & Administration
    • Ordering
    • Patient Resources
    • Finances & Access
  • Column 3
    • Privacy policy
    • Terms & conditions
    • Tolmar website

IMPORTANT SAFETY INFORMATION

Expand Minimize

ELIGARD®, (leuprolide acetate) for injectable suspension, is indicated for the palliative treatment of advanced prostate cancer.

ELIGARD is contraindicated in patients with hypersensitivity to GnRH, GnRH agonists, or any of the components of ELIGARD. Anaphylactic reactions to synthetic GnRH or GnRH agonists have been reported in the literature. Transient increase in serum levels of testosterone during treatment may result in worsening of symptoms or onset of new signs and symptoms during the first few weeks of treatment, including bone pain, neuropathy, hematuria, bladder outlet obstruction, ureteral obstruction, or spinal cord compression. Monitor patients at risk closely and manage as appropriate.

Hyperglycemia and an increased risk of developing diabetes have been reported in men receiving GnRH agonists. Monitor blood glucose level and manage according to current clinical practice. Increased risk of myocardial infarction, sudden cardiac death and stroke has also been reported with use of GnRH agonists in men. Monitor for cardiovascular disease and manage according to current clinical practice. Androgen deprivation therapy may prolong the QT/QTc interval. Consider risks and benefits. May cause fetal harm. Convulsions have been observed in patients taking leuprolide acetate with or without a history of predisposing factors. Manage convulsions according to current clinical practice.

ELIGARD may impair fertility in males of reproductive potential.

The most common injection site adverse events are transient burning and stinging, pain, bruising, and erythema. The most common systemic adverse events include mild to severe hot flashes/sweats, malaise and fatigue, weakness, myalgia, dizziness, clamminess, testicular atrophy, and gynecomastia. As with other GnRH agonists, other adverse reactions, including decreased bone density and rare cases of pituitary apoplexy have been reported.

See package insert for full prescribing and safety information.

Please see full Prescribing Information for ELIGARD and full Prescribing Information for ELIGARD with Pre-connected Syringe System.